Related Experiment Video
Updated: Jul 8, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Insight, quality of life, and functional capacity in middle-aged and older adults with schizophrenia
Ashley S Roseman1, John Kasckow, Ian Fellows
1University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. acsenior@hotmail.com
Objective:
The quality of life (QOL) for individuals with schizophrenia is determined by a number of factors, not limited to symptomatology. The current study examined lack of insight as one such factor that may influence subjective QOL or functional capacity. It was hypothesized that insight would significantly interact with symptom severity to influence subjective QOL. Insight was not expected to influence the relation between symptom severity and functional capacity.
Methods:
Participants were middle-aged and older outpatients who met diagnostic criteria for schizophrenia or schizoaffective disorder, and subsyndromal depression. Insight, psychopathology, and subjective QOL were assessed via semi-structured interviews and functional capacity was assessed via performance-based measures.
Results:
Insight interacts with negative symptom severity to predict subjective QOL. Severity of negative symptoms and insight contribute directly to functional capacity.
Conclusions:
Individuals with intact insight may be better able to manage their symptoms, resulting in improved QOL. Treatment implications for improving the QOL of middle age and older adults with schizophrenia are discussed.
Related Concept Videos
Cognitive Development During Adulthood
Schizophrenia
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychological and Sociocultural Causes of Schizophrenia
Pharmacodynamics in Geriatric Patients: Effects of Age